Search

As we cruise toward the holiday season, it’s been another good week for the market—as of this morning, the S&P 500 is up nearly 2% while the Nasdaq, S&P 400 Midcap and S&P 600 SmallCap (now up seven weeks in a row!) all are up in the 2.5% to 3% range.

Unsure of where to find profitable stocks in this highly volatile market? Here’s how to find COVID-19 stock market winners.

Investing isn’t all about buying when the market is hot. For the following three reasons, bad markets have their benefits too. (I’m a growth investor, which is a decision I only came to after I started working at Cabot, so these reasons apply to growth investing.)

The options market is vastly different now than it once was, thanks to computers. You can’t compete with algorithms, so what do you do?

Day trading is like gambling, which is why we don’t advise it. But that didn’t stop neophyte investor Dave Portnoy from doing it in the midst of a pandemic.

Do you prefer growth stocks, value stocks or income stocks? If you don’t know, now is the time to decide, before the market rebounds from the election.

Ahead of the long holiday weekend the market had yet another good week. The S&P 500 gained 1.75%, the Dow rallied 1.5%, and the Nasdaq rose another 1.9%.

This week in an attempt to diversify the portfolio we are adding an energy play.

We’re going to reel in a few profits during this post-election stock market surge in the event the honeymoon is short-lived. Along those lines, today I recommend you sell your remaining stake in Mitek (MITK), as well as sell half your position in LeMaitre Vascular (LMAT) and NanoString (NSTG).

SPACs and growth stocks rose in tandem in 2020 and 2021. Now both are struggling in the new bear market. One has more immediate upside.

After 16 relatively smooth weeks, the sellers have finally put up a fight this week, dragging most growth stocks down after big runs. We trimmed a bit earlier this week, selling one name and taking partial profits in another, leaving us with 20% in cash. But most of the evidence remains positive, and while we remain flexible, we’re comfortable giving most of our winners a chance to digest their recent moves.

This week’s issue writes about why a market pullback would make sense around here, but also talks about the most bullish factor we see (lots of early-stage leaders out there). And, as always, we give you all our latest ideas and thoughts on the market and our stocks, including key levels we’re watching.

It’s time to buy stocks more aggressively.

That’s the case for stocks in general, but also cannabis stocks. Most cannabis companies aren’t really affected by tariffs. But their stocks have been hit recently by the shift to “risk-off” mode among investors.

For anyone engaged in the forecasting business, the temptation is always present to make a sensational claim about the future in order to stand out from the crowd and garner mainstream media attention. And truth be told, for those of us whose livelihoods involve predicting financial markets, that temptation must often be suppressed in the interest of professionalism.

The flip of the calendar has brought some wild action, and overall, growth stocks and funds remain stuck in the mud, unable to make much progress (even including the Nasdaq itself). We remain cautious right now and, in fact, are placing two of our stocks on Hold today as they’ve been weighed down by the environment. That said, while we’re holding lots of cash, we remain flexible, as tons of names are in consolidations and are presenting at key conferences (which have become like earnings reports at times) next week—if we see many breakouts, we’ll pounce, but for now, we advise a bit more patience.